Cannabis Bioscience International Holdings, Inc. (CBIH)
CBIH is quoted over the counter, not listed on an exchange. Cannabis Bioscience International Holdings, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | CBIH, quoted over the counter |
| SEC CIK | 0001411057 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Services-Commercial Physical & Biological Research |
| Business address | Yantis, TX |
| Incorporated in | CO |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Going Concern As indicated in Note 3 of the notes to the audited consolidated financial statements for the period ended February 28, 2026, and the report thereon of the Company's independent auditing firm, there is substantial doubt as to the ability of the Company to continue as a going concern." | 10-Q 2026-04-16 |
| Cash and burn | $90 cash; operating cash flow -$67K a quarter. | Report 2026-02-28 |
| Shares outstanding | 11,626,749,347 (2026-04-16); 10,931,749,347 a year earlier. the newest SEC cover-page count is from 2026-04-16; shares issued since then are not in these figures. | Cover page 2026-04-16 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | VICTOR MOKUOLU CPA PLLC, Houston, Texas, United States | PCAOB Form AP 2025-11-17 |
| Late filings, 12 months | 4 NT notices | NT 10-Q 2026-10-16 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-02-28 | $11K | -$104K | -$15K | $90 | $291K | $124K | 10-Q 2026-04-16 |
| Q2 2026 2025-11-30 | $53K | -$117K | -$5K | $132 | $291K | $127K | 10-Q 2026-02-19 |
| Q1 2026 2025-08-31 | $24K | -$83K | -$104K | $223 | $287K | $148K | 10-Q 2025-10-22 |
| Q4 2025 2025-05-31 | $35K | -$212K | -$144K | $13K | $286K | $303K | 10-K 2025-09-22 |
| Q3 2025 2025-02-28 | $15K | -$181K | -$83K | $548 | $264K | $344K | 10-Q 2026-04-16 |
| Q2 2025 2024-11-30 | $74K | -$80K | -$72K | $1K | No debt tags | $365K | 10-Q 2026-02-19 |
| Q1 2025 2024-08-31 | $179K | -$76K | -$30K | $969 | $257K | $355K | 10-Q 2025-10-22 |
| Q4 2024 2024-05-31 | $76K | -$136K | -$174K | $755 | $256K | $249K | 10-K 2025-09-22 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 253G2 | 2026-07-01 |
| Latest annual report | 10-K | 2025-09-22 |
| Latest quarterly / interim | 10-Q | 2026-04-16 |
| Latest current report | 8-K | 2025-01-22 |
Source: SEC EDGAR submissions feed, 143 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier